Pharmafile Logo
Pharmafocus logo
Advanced Search

insulin

Showing 15 posts of 54 posts found.

5204602349_c87b204860_b

FDA approves artificial pancreas developed by the University of Virginia

January 2, 2020
Business Services, Medical Communications FDA, Pancreas, Type 1 diabetes, diabetes, insulin, type 2 diabetes

The FDA has approved an artificial pancreas system based on technology from the University of Virginia’s Center for Diabetes Technology. …

News
47699364212_411beea163_b

Eli Lilly CEO says Elizabeth Warren’s claims they failed on cheaper insulin is ‘nonsense’

December 18, 2019
Research and Development Bernie Sanders, Eli Lilly, Elizabeth Warren, US Pharma, US Presidential Election, insulin

David Ricks, the CEO of Eli Lilly, has said that Presidential candidate Senator Elizabeth Warren’s claims his company failed on …

News

Sanofi to move away from diabetes and cardiovascular, as company shakeup continues

December 10, 2019
Manufacturing and Production ASH 19, Sanofi, Sanofi Diabetes, Sanofi Insulin, diabetes, insulin

Sanofi has said it will stop investment and research into creating new diabetes and cardiovascular drugs, as part of the …

News
samsung_bioepis

South Korea jails executives for their role in Samsung Biologics fraud

December 10, 2019
Manufacturing and Production Samsung phones, Sanofi, Sanofi Diabetes, South Korea Healthcare System, South Korea Samsung, diabetes, inhaled insulin, insulin, south korea

Three executives of Samsung Electronics have been sentenced to jail for their role in committing fraud at its biotech affiliate …

News

Novo Nordisk set to launch price cut for insulin drug NovoLog after harsh criticism over prices in the US

September 9, 2019
Sales and Marketing Novo Nordisk, NovoLog, insulin

Danish drug maker Novo Nordisk has said it will offer a generic version of NovoLog (insulin aspart) at a price …

News

Cost of insulin doubled between 2012 and 2016

January 23, 2019
Research and Development USA, healthcare, insulin, insurance, pricing

The cost of insulin almost doubled in the United States between 2012 and 2016, according to a report by the …

News

Novo Nordisk stockpiles 16 weeks’ worth of insulin in preparation for hard Brexit

September 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Novo Nordisk, UK, brexit, insulin, pharma, stockpiles

Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are …

News
fdaoutsideweb

FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product

December 12, 2017
Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …

News

Sanofi launches patent infringement lawsuit against Mylan over diabetes pen

October 25, 2017
Research and Development, Sales and Marketing Basaglar, Eli Lilly, Lantus, Mylan, Sanofi, diabetes, insulin, patent infringement, pharma

Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …

News

Pioneering immunotherapy halts progression of type 1 diabetes

August 10, 2017
Research and Development Type 1 diabetes, diabetes, drugs, insulin, life sciences, medicines, pharma, pharmaceutical

In a first for the disease area, an immunotherapy treatment for diabetes, developed by researchers at King’s College London and …

News
insulin-syringe-1972843_960_720

Price-fixing class action lawsuit levelled at three major insulin producers

January 31, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing

A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …

News
jj_2johnson_and_johnson

Patients’ insulin pumps are revealed to be hackable by J&J

October 4, 2016
Research and Development, Sales and Marketing FDA, Hackers, Johnson & Johnson, diabetes, insulin

Johnson & Johnson have begun warning patients that their insulin pumps, that patients attach to their bodies and are controlled …

News
novonordisk

Novo Nordisk to cut 2% of its entire workforce

September 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Denmark, Novo Nordisk, diabetes, insulin, job cuts, job losses

Novo Nordisk, headquartered in Bagsvaerd, Denmark, has taken the decision to lose 1,000 of its workforce from a total global …

News
novo_nordisk_flag

Novo Nordisk to provide discounted insulin to poorest nations

September 23, 2016
Medical Communications, Sales and Marketing Novo Nordisk, diabetes, insulin

Danish pharma firm Novo Nordisk has announced its intention to provide insulin at discounted prices to the world’s poorest nations …

News
merckincweb

MSD insulin glargine biosimilar meets primary endpoint in late-stage trials

June 14, 2016
Manufacturing and Production, Research and Development, Sales and Marketing MSD, Merck, biosimilar, insulin, insuline glargine

MSD (NYSE: MRK), known as Merck in the US and Canada, has announced results from two Phase III studies evaluating …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025